GLP-1 injections, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are medications that help regulate blood sugar and reduce appetite. Originally developed for type 2 diabetes, they are now widely used for medical weight loss under professional supervision.

These medications mimic the GLP-1 hormone, which signals to your brain that you're full and slows down digestion. This helps reduce cravings, control portion sizes, and promote gradual, sustainable weight loss.

Ideal candidates are adults with a BMI of 27 or higher with weight-related health concerns, or a BMI of 30 and above. A consultation with our medical team will help determine if you're a good fit based on your health history and goals.

Most patients begin to notice changes in appetite and weight within the first few weeks. Significant weight loss typically occurs over several months with consistent use and lifestyle support.

Both semaglutide and tirzepatide are administered as once-weekly injections. Our team will teach you how to self-administer or provide in-clinic support as needed.

Both are highly effective GLP-1 medications. Tirzepatide (like Mounjaro) also targets a second hormone (GIP), which may offer even greater weight loss for some patients. We’ll help you choose the right option during your consultation